a public good project by the
Synthesis
Company
of California

© 2026

Kinetic Profiling of Clinical Symptoms and Basophil Parameters During Treatment of Chronic Spontaneous Urticaria with Omalizumab | doi.page

0 citations

Google Scholar doi.org

Kinetic Profiling of Clinical Symptoms and Basophil Parameters During Treatment of Chronic Spontaneous Urticaria with Omalizumab

Journal of Allergy and Clinical Immunology·2019·Vol. 143(2), pp. AB49–AB49

Citations Over Time

Kirti Johal, Donald W. MacGlashan, John T. Schroeder, E Oliver, Kristin Chichester, Sarbjit S. Saini

Related Papers

→ Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children(2014)42 cited
→ Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria(2020)11 cited
→ Kinetic Profiling of Clinical Symptoms and Basophil Parameters During Treatment of Chronic Spontaneous Urticaria with Omalizumab(2019)2 cited
→ Human monocytes generate basophil histamine-releasing activities.(1988)17 cited
→ Faculty Opinions recommendation of The Efficacy of Omalizumab Treatment in Chronic Spontaneous Urticaria is Associated with Basophil Phenotypes.(2021)